申请人:Eli Lilly and Company
公开号:US03968111A1
公开(公告)日:1976-07-06
8,8-Disubstituted-6-methylergolines and 9-ergolenes, prepared by alkylation of lysergic, isolysergic or their 9,10-dihydro analogues, optionally followed by chemical modification of an 8-substituent.
8,8-二取代-6-甲基-埃高啉和9-埃高烷是通过对裂脲菌碱、异裂脲菌碱或它们的9,10-二氢类似物进行烷基化制备的,随后可以选择性地对8-取代基进行化学修饰。